On the other hand, we observed an increased level of CD2-associated fluorescence in colorectal carcinomas (IFIS: 8.2 ± 1.5), and this gain was statistically significant with respect to NM and ACF (Figures 1(a), 2(a), 2(b), and 2(c)). The gene discussed is CD2; the disease is colorectal carcinoma.